Filgrastim desensitization in a patient with Hodgkin lymphoma

Pediatr Blood Cancer. 2022 Jan;69(1):e29394. doi: 10.1002/pbc.29394. Epub 2021 Oct 11.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols
  • Filgrastim / therapeutic use*
  • Granulocyte Colony-Stimulating Factor / therapeutic use
  • Hematopoietic Stem Cell Mobilization
  • Hodgkin Disease* / drug therapy
  • Humans
  • Lymphoma, Non-Hodgkin* / drug therapy
  • Polyethylene Glycols / therapeutic use
  • Recombinant Proteins / therapeutic use

Substances

  • Recombinant Proteins
  • Granulocyte Colony-Stimulating Factor
  • Polyethylene Glycols
  • Filgrastim